[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354932-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354932-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","utility-and-clinical-effectiveness-of-liquid-biopsy-based-dna-methylation-testing-in-early-tumor-screening-and-diagnosis-emphasizing-older-adult-populations-a-systematic-review-and-meta-analysis","Utility and clinical effectiveness of liquid biopsy-based DNA methylation testing in early tumor screening and diagnosis, emphasizing older adult populations - a systematic review and meta-analysis","","The systematic review and meta-analysis evaluates the diagnostic value and clinical effectiveness of liquid biopsy-based DNA methylation testing for early tumor screening and diagnosis, with emphasis on older adults. The study focuses on cysteinedioxygenase type 1 (CDO1) promoter methylation in liquid biopsies for lung cancer detection. Across seven included studies, pooled estimates quantify sensitivity, specificity, likelihood ratios, and diagnostic odds ratio. Findings indicate robust diagnostic accuracy with consistent performance across specimen types and geographic regions, supporting clinical utility as a minimally invasive screening option for older populations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/utility-and-clinical-effectiveness-of-liquid-biopsy-based-dna-methylation-testing-in-early-tumor-screening-and-diagnosis-emphasizing-older-adult-populations-a-systematic-review-and-meta-analysis/354932/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/utility-and-clinical-effectiveness-of-liquid-biopsy-based-dna-methylation-testing-in-early-tumor-screening-and-diagnosis-emphasizing-older-adult-populations-a-systematic-review-and-meta-analysis/354932.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biomarker and specimen type are evaluated in the review?","Question",{"text":63,"@type":64},"The review evaluates cysteinedioxygenase type 1 (CDO1) promoter methylation in liquid biopsies for lung cancer detection, using blood and nonblood specimens such as urine or sputum.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many studies and participants were included?",{"text":68,"@type":64},"Seven studies were included, totaling 655 lung cancer cases and 402 controls.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic accuracy does the review report?",{"text":72,"@type":64},"For blood-based liquid biopsies, pooled sensitivity and specificity were 0.72 and 0.89; for nonblood specimens they were 0.66 and 0.87. The overall diagnostic odds ratio was 19.13, with positive and negative likelihood ratios of 7.73 and 0.32.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354932,1790268925,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","TYPE Systematic Review PUBLISHED 12 January 2026 DOI 10.3389/fonc.2025.1739963  \nOPEN ACCESS  \nEDITED BY  \nLi-Yue Sun,  \nFudan University, China  \nREVIEWED BY  \nWeixing Wang,  \nRenmin Hospital of Wuhan University, China Wenjie Shi,  \nPius-Hospital Oldenburg, Germany Xintian Cai,  \nSichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, China SongOu Zhang,  \nNingbo University, China  \n*CORRESPONDENCE  \nMinli Li  \n [liminli_xh@163.com](liminli_xh@163.com)[ ](liminli_xh@163.com)Desheng Zhu  \n [dopikey@163.com](dopikey@163.com)  \n†These authors share ﬁrst authorship  \nRECEIVED 05 November 2025  \nREVISED 15 December 2025  \nACCEPTED 19 December 2025  \nPUBLISHED 12 January 2026  \nCITATION  \nGao Y, Xu H, Li J, Li M and Zhu D (2026) Utility and clinical effectiveness of liquid biopsy-based DNA methylation testing in early tumor screening and diagnosis, emphasizing older adult populations: a systematic review and meta-analysis.  \nFront. Oncol. 15:1739963 .  \ndoi: 10.3389/fonc.2025.1739963  \nCOPYRIGHT  \n© 2026 Gao, Xu, Li, Li and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nUtility and clinical effectiveness of liquid biopsy-based DNA methylation testing in early tumor screening and diagnosis, emphasizing older adult populations: a systematic review and meta-analysis  \nYujuan Gao 1†, Haoyu Xu 2†, Juan Li 3†, Minli Li 2* and Desheng Zhu 4*  \n1 Department of Radiation Oncology, Tai’an Cancer Hospital, Tai’an, China, 2 Department of Gastroenterology and Hepatology, Nanjing Jinling Hospital, Afﬁliated Hospital of Medical School, Nanjing University, Nanjing, China, 3 Department of Radiation Oncology, Jinling Hospital, Afﬁliated Hospital of Medical School, Nanjing University, Nanjing, China, 4 Department of Urology, Afﬁliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China  \nBackground: The global aging population faces a disproportionate burden of lung cancer, creating an urgent need for minimally invasive screening methods. Liquid biopsy-based DNA methylation testing, particularly targeting the cysteinedioxygenase type 1 (CDO1) gene promoter, has emerged as a promising approach for early cancer detection. This study aims to systematically evaluate the diagnostic value of CDO1 promoter methylation in lung cancer using liquid biopsies.  \nMethods: A comprehensive literature search was conducted across PubMed/ MEDLINE, Embase, Web of Science, and Cochrane Library from inception to 28Th September, 2025 . Studies reporting CDO1 promoter methylation in liquid biopsies (blood, urine, or sputum) for lung cancer detection with histological conﬁrmation were included. Methodological quality was assessed using QUADAS-2 . Bivariate random-effects models were used to calculate pooled sensitivity, speciﬁcity, diagnostic odds ratio (DOR), positive/negative likelihood ratios (PLR/NLR), and 95% conﬁdence intervals.  \nResults: Seven studies involving 655 lung cancer cases and 402 controls were included. CDO1 methylation demonstrated pooled sensitivity of 0 . 72 and speciﬁcity of 0 . 89 for blood-based liquid biopsies, and 0 . 66 and 0 . 87 for nonblood specimens, respectively. The overall diagnostic odds ratio was 19 . 13 (95% CI: 13 .53-26. 84), with positive and negative likelihood ratios of 7 .73 (95% CI: 5 .77- 10.35) and 0 .32 (95% CI: 0 .26-0.39) . No signiﬁcant heterogeneity was observed across studies (I² = 0% for all parameters) . Subgroup analyses revealed consistent performance across different specimen types and geographic regions.  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org","cbCaitS27v2MMjZ4","https://ap.wps.com/l/cbCaitS27v2MMjZ4","pdf",5407812,13,"English","# Background\n## Cancer risk in aging populations\n## Need for minimally invasive screening\n# Methods\n## Literature search and inclusion criteria\n## Quality assessment and statistical approach\n# Results\n## Included studies and pooled diagnostic performance\n## Subgroup analyses\n# Conclusion","[{\"question\":\"What biomarker and specimen type are evaluated in the review?\",\"answer\":\"The review evaluates cysteinedioxygenase type 1 (CDO1) promoter methylation in liquid biopsies for lung cancer detection, using blood and nonblood specimens such as urine or sputum.\"},{\"question\":\"How many studies and participants were included?\",\"answer\":\"Seven studies were included, totaling 655 lung cancer cases and 402 controls.\"},{\"question\":\"What diagnostic accuracy does the review report?\",\"answer\":\"For blood-based liquid biopsies, pooled sensitivity and specificity were 0.72 and 0.89; for nonblood specimens they were 0.66 and 0.87. The overall diagnostic odds ratio was 19.13, with positive and negative likelihood ratios of 7.73 and 0.32.\"}]","Utility and clinical effectiveness of liquid biopsy-based DNA methylation testing in early tumor screening and diagnosis, emphasizing older adult populations - a systematic review and meta-analysis | PDF",1790114911,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/487ea147f32c06bde89f7472f5804a01.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c7677430276bef986c7f956933fd946.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/226a42942289642bc07360d4e41a4553.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9c353ab4569c3c0616367a89e5333cb.webp",980,1385]